Emergence of multidrug resistance in leukemia cells during chemotherapy: Mechanisms and prevention

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 2, 2002, Pages 231-241

  Shtil, Alexander A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA AMANITIN; ANTINEOPLASTIC AGENT; CISPLATIN; COMPLEMENTARY DNA; CYTARABINE; DACTINOMYCIN; DIACYLGLYCEROL; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; HYDROXYUREA; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PIROXICAM; PROTEIN KINASE C; RETINOID; RHODAMINE 123; SALICYLATE SODIUM; STAUROSPORINE; SULINDAC; TRABECTEDIN; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNINDEXED DRUG; VINCRISTINE; XENOBIOTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CHROMATIN; DRUG EFFICACY; GENE; HUMAN; LEUKEMIA CELL; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION; GENES, MDR; HUMANS; LEUKEMIA; P-GLYCOPROTEINS;

EID: 0036223370     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581602753658439     Document Type: Review

References (113)

1. Active outward transport of daunorubicin in resistant Ehrlich ascites tumor cells
2. Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells
3. Genetic and biochemical characterization of multidrug resistance
4. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
5. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines
6. ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells
7. Purification of the 170-to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase
8. Expression of the human multidrug resistance cDNA in insect cells generates a high activity of drug-stimulated membrane ATPase
9. P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity
10. Structure of the multidrug resistance Pglycoprotein
11. Chromosomal localization in normal human cells and CHO cells of a sequence derived from P-glycoprotein (PGY1)
12. Localization of multidrug resistance-associated DNA sequences to human chromosome 7
13. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
14. Multidrug resistance in DNA mediated transformants is linked to transfer of the human mdr1 gene
15. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine
16. Reversal of multidrug resistance by calcium channel blockers and other agents
17. Expression of the multidrug resistance gene in human cancer
18. Multidrug resistance gene expression in childhood medulloblastoma: Correlation with clinical outcome and DNA ploidy in 29 patients
19. Prognostic relevance of P-glycoprotein expression in breast cancer
20. Cytogenetics and P-glycoprotein (Pgp) are independent predictors of treatment outcome in acute myeloid leukemia (AML)
21. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma
22. The prognostic value of MDR1 gene expression in primary untreated neuroblastoma
23. Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression
24. Prognostic value of P-glycoprotein and leukocyte differentiation antigens in chronic myeloid leukemia
25. Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin
26. Drug resistance and sensitivity of germ cell testicular tumors: Evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins
27. Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia leukaernia cells predict a poor response to chemotherapy and reduced patient survival
28. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute nonlymphoid leukaemias: Biological and clinical implications
29. Studies of some mechanisms of drug resistance in chronic myeloid leukemia (CML)
30. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells
31. Regulation of MDR1 gene expression: Emerging concepts
32. Multidrug resistance-multiplex phenomenon
33. The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions
34. Multidrug resistance: Molecular and clinical aspects
35. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NFκB/p65 and c-Fos transcription factors and their interaction with the CAAT region
36. Recent progress in P-glycoprotein research
37. Identification and characterization of the MDRI promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line
38. Multidrug resistance-associated protein subfamily transporters and drug resistance
39. Novel mechanisms of drug resistance in leukemia
40. Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentiation
41. Modulation of the expression of a multidrug resistance gene (mdr1/P-glycoprotein) by differentiating agents
42. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells
43. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation
44. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs
45. Use of fluorescent dyes as molecular probes for the study of multidrug resistance
46. Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-PEG-fatty acid diesters, novel inhibitors of P-glycoprotein function
47. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation
48. Protein kinase C: Structure, function, and regulation
49. Lipid mediators and protein kinase C for intracellular signaling
50. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists
51. 60 Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation
52. Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways
53. Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species
54. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
55. 12-O-tetradecanoylphorbol 13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase
56. Ceramide inhibits protein kinase C (PKC) activity and activates the MDR1 gene in human leukemia cells: Evidence for a PKC-independent mechanism of up-regulation of multidrug resistance
57. Signal transduction by MAP kinases in T lymphocytes
58. Activation of phospholipase C induces the expression of the multidrug resistance (MDR 1) gene through the Raf-MAPK pathway
59. Adriamycin activates c-Jun N-terminal kinase in human leukemia cells: A relevance to apoptosis
60. Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates
61. Enhancement of chemotherapeutic agents-induced apoptosis associated with activation of c-Jun N-terminal kinase 1 and caspase 3 (CPP32) in bax-transfected gastric cancer cells
62. Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-c-Jun NH2-terminal kinase pathway
63. How NFKB is activated: The role of IκB kinase (IKK) complex
64. NF-κB as a primary regulator of the stress response
65. Signal-induced site-specific phosphorylation targets IKBa to the ubiquitin-proteasome pathway
66. Control of IκBα proteolysis by site-specific, signal-induced phosphorylation
67. Mapping of the inducible IκBα phosphorylation sites that signal its ubiquitination and degradation
68. Stimulation-dependent IKBa phosphorylation marks the NF-KB inhibitor for degradation via the ubiquitin-proteasome pathway
69. Signal-induced degradation of IκB requires site-specific ubiquitination
70. The ubiquitin system
71. Activation of interleukin-6 gene expression through the NFKB transcription factor
72. Dithiocarbamates as potent inhibitors of nuclear factor KB activation in intact cells
73. Pyrrolidine dithiocarbamate inhibits NF-KB mobilization and TNF production in human monocytes
74. Inhibition of NFKB by sodium salicylate and aspirin
75. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is bound to NF-KB
76. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κB
77. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
78. Regulation of RANTES chemokine gene expression requires cooperativity between NF-KB and IFN-regulatory factor transcription factors
79. Involvement of nuclear factor-kappa B (NF-kappa B) activation in mitogen-induced lymphocyte proliferation: Inhibitory effects of lymphoproliferation by salicylates acting as NF-kappa B inhibitors
80. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation
81. Mechanism of action of nonsteroidal anti-inflammatory drugs
82. Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-KB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis
83. IEX-1L, an apoptosis inhibitor involved in NFκB-mediated cell survival
84. NF-κB inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
85. NF-κB inhibits apoptosis in murine mammary epithelia
86. NF-KB activation by camptothecin
87. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene
88. Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdrl gene in vivo
89. The human multidrug resistance (MDR1) gene: cDNA cloning and transcription initiation
90. Structure and expression of the human MDR (P-glycoprotein) gene family
91. Signal transduction pathways and transcriptional mechanisms as targets for prevention of emergence of multidrug resistance in human cancer cells
92. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1
93. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter
94. Carnosic acid and promotion of monocyte differentiation of HL60-G cells initiated by other agents
95. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children
96. ATRA(ouble) in the treatment of acute promyelocytic leukemia
97. Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation
98. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: A new approach to anti-leukemia therapy
99. Inhibitors of histone deacetylase relieve ETO-mediated·repression and induce differentiation of AML1 AMLl-ETO leukemia cells
100. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans RA
101. Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines
102. Activation of MDR1 transcription by ATRA in neuroblastoma cells is mediated by a complex interplay of multiple Sp family members
103. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y
104. Transcriptional regulation of MDR genes
105. Differential utilization of multiple transcription start points accompanies the over-expression of the P-glycoprotein-encoding gene in Chinese hamster lung cells
106. Accumulation of glucosylceramide in multidrug-resistant cancer cells
107. Glucosylceramide: A marker for multiple-drug resistant cancers
108. Overexpression of the MDR1 gene is associated with a decreased mitochondrial transmembrane potential in K562 human leukemia cells selected for P-glycoprotein-mediated multidrug resistance
109. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis
110. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death
111. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway